Patents/Assignees

EXTROVIS AG

4 patents in portfolio

US12569434utility2026
Formulations of Nebivolol
0 cites
US12303506utility2025
Trabectedin Composition
0 cites
US11642358utility2023
Stable Pharmaceutical Formulation
0 cites
US11541066utility2023
Stable Ready-to-use Parenteral Compositions of Fosaprepitant
0 cites